NERV short interest
Minerva Neurosciences Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 2,435,917 |
|---|---|
| Change vs prior report | 14,265 (+0.6%) |
| Change over six months | +138.6% |
| Days to cover | 12.96 (sector: 3.78) |
| Average daily volume | 187,984 |
| Rank in Healthcare | #58 of 922 by days to cover |
NERV short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 2,435,917 | +0.6% | 12.96 | 187,984 |
| 2026-09-15 | 2,421,652 | +14.6% | 20.13 | 120,275 |
| 2026-08-31 | 2,112,663 | +20.3% | 6.35 | 332,755 |
| 2026-08-14 | 1,755,972 | -28.2% | 11.76 | 149,367 |
| 2026-07-31 | 2,447,362 | +1.1% | 15.54 | 157,495 |
| 2026-07-15 | 2,420,231 | +27.1% | 12.52 | 193,281 |
| 2026-06-30 | 1,904,425 | +70.2% | 3.23 | 589,572 |
| 2026-06-15 | 1,118,602 | +13.8% | 10.60 | 105,486 |
| 2026-05-29 | 982,569 | -17.2% | 5.68 | 173,002 |
| 2026-05-15 | 1,186,903 | -10.6% | 10.73 | 110,616 |
| 2026-04-30 | 1,327,415 | +14.8% | 7.90 | 168,058 |
| 2026-04-15 | 1,156,257 | +13.3% | 5.07 | 227,933 |
| 2026-03-31 | 1,020,925 | +82.5% | 1.90 | 538,544 |
| 2026-03-13 | 559,530 | +27.8% | 2.00 | 279,173 |
| 2026-02-27 | 437,962 | +1.2% | 5.22 | 83,830 |
| 2026-02-13 | 432,784 | +7.5% | 3.24 | 133,538 |
| 2026-01-30 | 402,585 | +25.3% | 6.06 | 66,424 |
| 2026-01-15 | 321,379 | -3.1% | 4.19 | 76,694 |
| 2025-12-31 | 331,605 | -7.6% | 8.67 | 38,231 |
| 2025-12-15 | 359,016 | +10.6% | 7.19 | 49,907 |
| 2025-11-28 | 324,754 | +3.9% | 3.67 | 88,491 |
| 2025-11-14 | 312,558 | -23.3% | 3.31 | 94,406 |
| 2025-10-31 | 407,275 | +594.1% | 1.00 | 14,449,529 |
| 2025-10-15 | 58,678 | +50.6% | 1.00 | 1,225,525 |
| 2025-09-30 | 38,956 | -4.0% | 2.01 | 19,393 |
import finzdata as yf
yf.Ticker("NERV").short_interest # every report since 2017
yf.Client().short_interest(["NERV"], start="2018-01-01")Healthcare short interest · NERV price history · Who owns NERV · All short interest